Stockscreener 앱 받기
1.65
20.44%
0.28
시간 외 거래:
29.72
28.07
+1,701%
Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스
Leading vs lagging indicators on Relmada Therapeutics Inc. performanceMarket Growth Summary & Scalable Portfolio Growth Methods - Newser
Identifying reversal signals in Relmada Therapeutics Inc.2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
What the charts say about Relmada Therapeutics Inc. todayWeekly Investment Recap & Consistent Return Investment Signals - Newser
Relmada Therapeutics CMO Purchases 55,000 Shares - MSN
Is Relmada Therapeutics Inc. still worth holding after the dipQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
Can machine learning forecast Relmada Therapeutics Inc. recoveryMarket Sentiment Review & Weekly High Conviction Trade Ideas - Newser
Using Bollinger Bands to evaluate Relmada Therapeutics Inc.Market Movers & Real-Time Chart Breakout Alerts - Newser
Is Relmada Therapeutics Inc. stock undervalued right nowRate Cut & AI Enhanced Trading Alerts - خودرو بانک
Is Relmada Therapeutics Inc. currently under institutional pressureJuly 2025 Setups & Growth Focused Investment Plans - خودرو بانک
Statistical indicators supporting Relmada Therapeutics Inc.’s strengthAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Is Relmada Therapeutics Inc. trending in predictive chart modelsWeekly Investment Report & Verified Swing Trading Watchlist - Newser
Price momentum metrics for Relmada Therapeutics Inc. explainedWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - Newser
How sentiment analysis helps forecast Relmada Therapeutics Inc.Oil Prices & High Yield Stock Recommendations - Newser
What is Relmada Therapeutics Inc. s P E ratio telling us2025 Retail Activity & Safe Entry Momentum Tips - 더경남뉴스
Market reaction to Relmada Therapeutics Inc.’s recent news2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
What’s the analyst consensus on Relmada Therapeutics Inc.Portfolio Growth Summary & Accurate Intraday Trade Tips - خودرو بانک
Will Relmada Therapeutics Inc. see short term momentumJuly 2025 Retail & Growth Focused Stock Reports - Newser
Fed Meeting: Is Relmada Therapeutics Inc. impacted by rising rates2025 Earnings Surprises & Weekly Market Pulse Updates - خودرو بانک
Is Relmada Therapeutics Inc. a candidate for recovery playMarket Volume Report & Weekly High Return Stock Forecasts - Newser
Can Relmada Therapeutics Inc. maintain its current growth rateJuly 2025 Outlook & Technical Entry and Exit Tips - خودرو بانک
Can technical indicators confirm Relmada Therapeutics Inc.’s reversalJuly 2025 Volume & AI Driven Price Forecasts - Newser
Should you wait for a breakout in Relmada Therapeutics Inc.M&A Rumor & Low Volatility Stock Suggestions - Newser
Market Catalysts: Will Relmada Therapeutics Inc. benefit from government policyJuly 2025 Earnings & Fast Gaining Stock Reports - خودرو بانک
Is now a turning point for Relmada Therapeutics Inc.2025 Top Decliners & Safe Swing Trade Setups - Newser
Exclusive: Relmada CEO says his recent buy reflects ’significant undervaluation’ - Investing.com
Relmada Therapeutics Inc. Price Targets Raised After ReboundGap Up & Weekly High Momentum Picks - beatles.ru
Analyzing recovery setups for Relmada Therapeutics Inc. investorsJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Will Relmada Therapeutics Inc. continue its uptrendShort Setup & Smart Money Movement Alerts - Newser
Published on: 2025-09-03 14:56:26 - خودرو بانک
Published on: 2025-09-03 04:51:26 - Newser
Real time scanner hits for Relmada Therapeutics Inc. explained2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Analyzing drawdowns of Relmada Therapeutics Inc. with statistical toolsMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How to integrate Relmada Therapeutics Inc. into portfolio analysis tools2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Using R and stats models for Relmada Therapeutics Inc. forecasting2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
Can Relmada Therapeutics Inc. be recession proofQuarterly Portfolio Review & Capital Efficiency Focused Ideas - خودرو بانک
What is Relmada Therapeutics Inc. s revenue forecastJuly 2025 Pullbacks & Short-Term High Return Ideas - خودرو بانک
Can momentum traders help lift Relmada Therapeutics Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Relmada Therapeutics executive purchases 55,000 shares on open market - Investing.com
Relmada Therapeutics executive purchases 55,000 shares on open market By Investing.com - Investing.com UK
What’s next for Relmada Therapeutics Inc. stock priceMarket Performance Report & Real-Time Buy Zone Alerts - Newser
Relmada Therapeutics (RLMD): Is the 91% Response Rate in Bladder Cancer a Catalyst for a Phase 3-Driven Bull Run? - AInvest
Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study - Insider Monkey
Is Relmada Therapeutics Inc.’s growth already priced inQuarterly Growth Report & Fast Moving Trade Plans - 한국정경신문
1.40%
자본화:
|
볼륨(24시간):